News
Carlyle backs Essential refinancing and other funding news
Private equity group Carlyle has joined forces with other investors …
20126 items found
Sales & Marketing
“The JPM of Europe” – London Life Sciences Week grows in stature as markets rebound
With its double-header of conferences held in London, mid-November is …
Digital
Why it's vital to minimise waste to make a more sustainable drug discovery industry a reality
Incorporating environmentally friendly practices has become …
News
NIH abandons trial of SIGA's mpox drug
Another clinical trial has found that SIGA Technologies' antiviral …
News
Why is colorectal cancer rising in younger age groups?
A new study has confirmed that the rate of colorectal cancer is …
Patients
Do we need to rethink the role of private healthcare in patient access to medication?
Timely patient access to medication has become an acute problem in …
News
Lynparza boosts long-term survival in early breast cancer
AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term …
News
Price deal opens door to NHS use of Santhera DMD drug
Santhera's Duchenne muscular dystrophy (DMD) therapy Agamree has been …
News
Lilly adds another sales channel for obesity drug Zepbound
Telehealth company Ro will offer single-dose vials of Eli Lilly's …
Oncology
Can CAR-T first movers keep pace in a rapidly evolving market?
The CAR-T landscape has quickly transformed from a pioneering …
R&D
Targeting proteins to bring new medicines to patients with few options
In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks …
News
Mulvany hits the reset button at BenevolentAI
The shape of BenevolentAI following the return of co-founder Ken …
News
Algorithm spots common sleep disorder linked to dementia
An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
